Skip to main content

Table 2 Clinical features of patients with RDD mimic IgG4-RD, RDD or IgG4-RD

From: Rosai–Dorfman disease mimicking IgG4-related diseases: a single-center experience in China

 

RDD mimic IgG4-RD (%)

RDD (%)

RDD total (%)

IgG4-RD (%)

p valuea

Age (years)

56(29–63)

52.5(28–81)

52.5(28–81)

54(21–75)

Sex (M/F)

7/0

7/3

14/3

21/13

Site of involvement

Lacrimal and salivary glands (LSG)

2/7(28.6)

1/10(10.0)

3/17(17.6)

21/34(61.8)

0.0065

 Lymph node

1/7(14.3)

5/10(50.0)

6/17(35.3)

20/34(58.8)

0.1441

 Pancreas

1/7(14.3)

0/10(0.0)

1/17(5.9)

8/34(23.5)

0.2412

 Liver

1/7(14.3)

0/10(0.0)

1/17(5.9)

1/34(2.9)

> 0.9999

 Endocranium, dura mater, sellar region

5/7(71.4)

1/10(10.0)

6/17(35.5)

1/34(2.9)

0.0038

 Retroperitoneum

0/7(0.0)

0/10(0.0)

0/17(0.0)

4/34(11.8)

0.2876

 Skin

1/7(14.3)

1/10(10.0)

2/17(11.8)

1/34(2.9)

0.5420

  1. M, male; F, female
  2. aMann–Whitney test between RDD total and IgG4-RD. RDD total group includes all the patients in RDD mimic IgG4-RD group and RDD group